GLSI Insider Trading Activity and SEC Form 4 Filings
GLSI insider trading summary
Over the past 12 months, insiders at Greenwich LifeSciences, Inc. (GLSI) reported 11 open-market purchases worth $473K by 1 insider and no sales on SEC Form 4. Net insider buying was $473K.
Latest GLSI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Snehal Patel | CEO and CFO | Buy | $9K (700 @ $13.10) |
| Jul 28, 2026 | Snehal Patel | CEO and CFO | Buy | $20K (1,500 @ $13.59) |
| Jul 27, 2026 | Snehal Patel | CEO and CFO | Buy | $20K (1,500 @ $13.62) |
| Jul 24, 2026 | Snehal Patel | CEO and CFO | Buy | $14K (1,100 @ $12.88) |
| Jul 23, 2026 | Snehal Patel | CEO and CFO | Buy | $33K (2,500 @ $13.14) |
| Jan 13, 2026 | Snehal Patel | CEO and CFO | Buy | $54K (1,800 @ $29.83) |
| Jan 12, 2026 | Snehal Patel | CEO and CFO | Buy | $80K (2,900 @ $27.54) |
| Dec 30, 2025 | Snehal Patel | CEO and CFO | Buy | $63K (2,900 @ $21.73) |
| Dec 18, 2025 | Snehal Patel | CEO and CFO | Buy | $52K (4,100 @ $12.62) |
| Nov 25, 2025 | Snehal Patel | CEO and CFO | Buy | $39K (4,600 @ $8.37) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.